What people love about Liraglutide, Novo Nordisk's FDA-approved drug you may know as Victoza for diabetes or Saxenda for weight loss, is that it's the GLP-1 that paved the road for the entire weight loss peptide revolution—and it's still holding its own. It works by mimicking the incretin hormone your gut releases after eating, telling your brain you're full and slowing down how fast food leaves your stomach, which means you naturally eat less without white-knuckling through hunger. The daily dosing is actually a feature for some people—if something doesn't agree with you, the effects clear faster than weekly options like Semaglutide, which gives you more control over the experience. Years of real-world clinical data across millions of prescriptions make this one of the most well-understood weight loss tools on the market. If you want the GLP-1 benefit with maximum flexibility and the comfort of an established safety record, Liraglutide is the proven path.
Applications: Weight Loss, Metabolism Support, Cardiovascular, Blood Sugar
Written by Peppa at Peptide Upside — the peptide lifestyle guide. Research, calculate, and track your peptide journey.